Corcept Therapeutics (CORT) Change in Receivables (2012 - 2026)
Corcept Therapeutics (CORT) posted Change in Receivables of $37.8 million for Q2 2026, up 282.72% sequentially from -$20.7 million in Q1 2026, and up 1277.29% YoY from $2.7 million in Q2 2025.
Corcept Therapeutics (CORT) Change in Receivables (2012 - 2026) Analysis & Trends
Corcept Therapeutics has reported Change in Receivables for 15 years, with the latest figure at $37.8 million in Q2 2026.
- Quarterly Change in Receivables rose 1277.29% year-over-year to $37.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $12.4 million (up 15.13% YoY) and the FY2025 annual result came in at $5.8 million, down 54.8% from the prior year.
- Change in Receivables grew to $37.8 million in Q2 2026 per CORT's latest filing, from -$20.7 million in the prior quarter.
- Over five years, Change in Receivables peaked at $37.8 million in Q2 2026 and troughed at -$20.7 million in Q1 2026.
- A 5-year average of $2.7 million and a median of $1.6 million in 2022 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2024 and 2026: Change in Receivables slumped 191925.0% in 2024, then soared 1277.29% in 2026.
- Over 5 years, Change in Receivables stood at $1.6 million in 2022, then jumped by 295.44% to $6.5 million in 2023, then slumped by 188.36% to -$5.7 million in 2024, then tumbled by 71.45% to -$9.8 million in 2025, then soared by 484.52% to $37.8 million in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered $37.8 million, -$20.7 million, and -$9.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn | 37.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.85 Mn |
| Jun 30, 2026 | 37.85 Mn |
| Mar 31, 2026 | -20.71 Mn |
| Mar 31, 2026 | -20.71 Mn |
| Dec 31, 2025 | -9.84 Mn |
| Dec 31, 2025 | -9.84 Mn |
| Sep 30, 2025 | 5.06 Mn |
| Sep 30, 2025 | 5.06 Mn |
| Jun 30, 2025 | 2.75 Mn |
| Jun 30, 2025 | 2.75 Mn |
| Mar 31, 2025 | 7.84 Mn |
| Mar 31, 2025 | 7.84 Mn |
| Dec 31, 2024 | -5.74 Mn |
| Dec 31, 2024 | -5.74 Mn |
| Sep 30, 2024 | 5.88 Mn |
| Sep 30, 2024 | 5.88 Mn |
| Jun 30, 2024 | -7.68 Mn |
| Jun 30, 2024 | -7.68 Mn |
| Mar 31, 2024 | 20.40 Mn |
| Mar 31, 2024 | 20.40 Mn |